Omgene Life Sciences

Omgene Life Sciences Private Limited is an R&D focused company that was established in March 2011 and has been active for approximately 12 years in the field of bio-pharmaceutical research. At Omgene, we are engaged in specialized research for developing Peptide API, semi-Synthetic API, Synthetic API compounds, biopharmaceuticals, and complex generics for critical care such as cancer treatment, infertility, obesity, diabetes, and various renal issues. We have successfully created and expanded approximately 25 Peptides.